BexBack Crypto Exchange Launches No KYC, 100x Leverage, and Double Deposit Bonus for Crypto Futures Trading
SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- With the price of Bitcoin (BTC) holding above $100,000 for a long time, many analysts are predicting that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to generate short-term profits in such conditions. As a result, 100x leverage futures trading has become the preferred tool for seasoned investors looking to maximize potential gains in this volatile market. BexBack Exchange is ramping up its efforts to offer traders unmatched promotional packages. The platform now features a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage on cryptocurrency trading, providing exceptional opportunities for investors.
Advantages of 100x Leverage Crypto Futures
What Is 100x Leverage and How Does It Work?
Simply put, 100x leverage allows you to open larger trading positions with less capital. For example:
Suppose the Bitcoin price is $100,000 that day, and you open a long contract with 1 BTC. After using 100x leverage, the transaction amount is equivalent to 100 BTC.
One day later, if the price rises to $105,000, your profit will be (105,000 - 100,000) * 100 BTC / 100,000 = 5 BTC, a yield of up to 500%.
With BexBack's deposit bonus
BexBack offers a 100% deposit bonus. If the initial investment is 2 BTC, the profit will increase to 10 BTC, and the return on investment will double to 1000%.
Note: Although leveraged trading can magnify profits, you also need to be wary of liquidation risks.
How Does the 100% Deposit Bonus Work?
The deposit bonus from BexBack cannot be directly withdrawn but can be used to open larger positions and increase potential profits. Additionally, during significant market fluctuations, the bonus can serve as extra margin, effectively reducing the risk of liquidation.
About BexBack?
BexBack is a leading cryptocurrency derivatives platform offering up to 100x leverage on futures contracts for BTC, ETH, ADA, SOL, XRP, and over 50 other digital assets. Headquartered in Singapore, the platform also operates offices in Hong Kong, Japan, the United States, the United Kingdom, and Argentina. Like many top-tier exchanges, BexBack holds a U.S. MSB (Money Services Business) license and is trusted by more than 500,000 traders worldwide. The platform accepts users from the United States, Canada, and Europe, with zero deposit fees and 24/7 multilingual customer support, delivering a secure, efficient, and user-friendly trading experience.
Why recommend BexBack?
No KYC Required: Start trading immediately without complex identity verification.
100% Deposit Bonus: Double your funds, double your profits.
High-Leverage Trading: Offers up to 100x leverage, maximizing investors' capital efficiency.
Demo Account: Comes with 10 BTC in virtual funds, ideal for beginners to practice risk-free trading.
Comprehensive Trading Options: Feature-rich trading available via Web and mobile applications.
Convenient Operation: No slippage, no spread, and fast, precise trade execution.
Global User Support: Enjoy 24/7 customer service, no matter where you are.
Lucrative Affiliate Rewards: Earn up to 50% commission, perfect for promoters.
Take Action Now—Don't Miss Another Opportunity!
If you missed the previous crypto bull run, this could be your chance. With BexBack's 100x leverage and 100% deposit bonus and $50 bonus for new users (complete one trade within one week of registration), you can be a winner in the new bull run.
Sign Up Now on BexBack — Break the 100x Leverage and KYC Barriers, Get Double Deposit Bonus and $50 Welcome Bonus Instantly
Website: www.bexback.com
Contact: [email protected]
Contact:
Amanda
[email protected]
Disclaimer: This content is provided by BexBack.The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice.Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed.Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.
Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/7dfb4b28-6c1c-4807-b56a-9f0077e16f8a
https://www.globenewswire.com/NewsRoom/AttachmentNg/1715add7-36d6-4509-991e-e8f9c63d7013
https://www.globenewswire.com/NewsRoom/AttachmentNg/5cf81239-b590-4b4f-9a04-5e124230c593
https://www.globenewswire.com/NewsRoom/AttachmentNg/1a763e64-1502-4c9b-9021-2bf71803e5cf
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
11 minutes ago
- Bloomberg
Macau Gaming Revenue Soars Past Estimate on Concert Fervor
Macau's monthly gaming revenue rose 19% in June, exceeding analyst expectations as visitors poured in to the world's biggest gambling hub for Cantonese pop concerts and other entertainment offerings. Gross gaming revenue reached 21.1 billion patacas ($2.6 billion) for the month, according to data released by the Gaming Inspection and Coordination Bureau on Tuesday. That was better than the median analyst estimate of a 9.4% year-on-year increase, and marks a return to 88% of the pre-pandemic level seen in 2019.
Yahoo
16 minutes ago
- Yahoo
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan
-- Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development -- TOKYO, July 01, 2025--(BUSINESS WIRE)--The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as "PHCbi"), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as "PHCHD") announces it has signed an exclusive agreement with MaxCyte, Inc. to distribute the MaxCyte ExPERT platform(*1) in Japan. In Singapore, SciMed (Asia) Pte Ltd, a subsidiary of PHCHD, separately entered into an exclusive distribution agreement with MaxCyte and launched the ExPERT platform in the country in June. MaxCyte is a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics. Under this partnership, PHCbi will offer sales and service support for MaxCyte's instruments, consumables, and solutions, providing researchers and manufacturers with access to a clinically proven, non-viral cell engineering platform. MaxCyte's ExPERT instrument portfolio is the next generation of leading, clinically and commercially validated electroporation technology for complex and scalable cell engineering. By enabling high transfection efficiency and cell viability, seamless scalability and enhanced functionality, the ExPERT platform delivers the high-end performance essential to enabling the next wave of biological and cellular therapeutics. PHCbi will distribute and support the full range of MaxCyte platforms covered under this agreement, including the ExPERT ATx®, ExPERT STx®, ExPERT GTx® and ExPERT VLx® as well as related consumables such as processing assemblies and electroporation buffers. These platforms are used by researchers worldwide and have been referenced in more than 70 clinical programs as of Q1 2025. Chikara Takauo, Director of PHC Corporation and General Manager of PHCbi, commented: "We are pleased to add the MaxCyte's ExPERT instruments to our cell culture technology portfolio. Guided by our vision of 'contributing to the evolution and progress of therapeutic modalities,' we are committed to expanding new solutions that address the challenges of QCD (Quality, Cost, and Delivery) in cell and gene therapy (CGT) manufacturing processes. The addition of MaxCyte's ExPERT portoflio allows us to better support scientists and cell therapy developers by providing them with a powerful, non-viral tool to advance their cell-based research and development processes and ultimately accelerate the adoption of CGT." The addition of MaxCyte's ExPERT platform complements PHCbi's ongoing efforts to further enhance the efficiency of CGT development and manufacturing processes while improving cell quality and safety. PHCbi recently introduced the LiCellMoTM live-cell metabolic analyzer(*2) for research use, incorporating PHC's core In-Line Monitoring technology. In addition, PHCbi is developing the LiCellGrowTM cell expansion system, which is being designed to optimize the cell culture environment by automatically exchanging culture medium based on the metabolic state of cells. Together with the MaxCyte's platform, these solutions reflect PHCbi's commitment to delivering comprehensive support for researchers and developers working in areas such as regenerative medicine, immunotherapy, and bioproduction as well as accelerating cell-based innovation in Japan and Singapore. PHCbi will showcase the ExPERT Platform at the 7th Regenerative Medicine EXPO Tokyo 2025 in Japan, which will be held at Japan's Tokyo Big Sight from July 9 to July 11, 2025. 7th Regenerative Medicine EXPO Tokyo 2025Dates: July 9 (Wed.) - 11 (Fri.), 2025Venue: Tokyo Big Sight Japan, West Exhibition Halls (PHCbi Booth No.: W5-30)Official Website: INTERPHEX Week Tokyo / Regenerative Medicine Expo Tokyo (*1) Product information: MaxCyte's instruments are not classified as a medical device. (*2) Product information: Live Cell Metabolic Analyzer | PHCbi About the Biomedical Division of PHC CorporationEstablished in 1969, PHC Corporation is a Japanese subsidiary of PHC Holdings Corporation (TSE 6523), a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, life sciences and diagnostics. The Biomedical Division supports the life sciences industry helping researchers and healthcare providers in around 110 countries and regions through its PHCbi-branded laboratory and equipment and services including CO2 incubators and ultra-low temperature About PHC Holdings Corporation (PHC Group)PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Ascensia Diabetes Care, Epredia, LSI Medience Corporation, Wemex and Mediford. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, diagnostics and life sciences. PHC Group's consolidated net sales in FY2024 were JPY 361.6 billion with global distribution of products and services in more than 125 About SciMed (Asia) Pte LtdSciMed (Asia) Pte Ltd, headquartered in Singapore, is an established and leading provider of products and services for biomedical, life sciences, healthcare, drug discovery, pharmaceutical, laboratories, industrial tests, and agricultural markets. SciMed has become the wholly owned subsidiary of PHC Holdings Corporation in 2023, advancing sales and marketing in life sciences business across Southeast Asia, India, and About MaxCyte, MaxCyte, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation™ technology and SeQure DX™ gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we've been advancing cell engineering, shaping the future of medicine. Learn more at and follow us on X and LinkedIn. View source version on Contacts Contact for media inquiries:Investor Relations & Corporate Communications DepartmentPHC Holdings CorporationTEL: +81-3-6778-5311E-mail: phc-pr@ Contact for product and service:Marketing Department, Biomedical Division PHC CorporationE-mail: Sign in to access your portfolio
Yahoo
16 minutes ago
- Yahoo
Trip.com Group Pioneers a Greener, More Inclusive Global Travel Ecosystem in 2024 Sustainability Report
Group launches new full-scale carbon emissions data feature across transport modes Country Retreats Programme expands to more global destinations, driving rural development Championing greater inclusion in the workplace SINGAPORE, July 1, 2025 /PRNewswire/ -- Group, a leading global travel service provider, has released its latest Sustainability Report. The report highlights the company's significant progress in sustainability, centred around its "Friendly Four" framework - Stakeholder-Friendly, Community-Friendly, Family-Friendly, and Environmentally-Friendly. It captures key highlights of the Group's efforts to advance a more sustainable and inclusive future through innovation, collaboration, and responsible growth. Comprehensive carbon emissions data launched across transport and accommodation modes As part of its commitment to making sustainable travel accessible, Group has launched a new feature that offers quantified carbon emissions data across all major transportation services - including flights, car rentals, airport transfers, and trains (European trains). With the support of the Association of Car Rental Industry System Standards (ACRISS), users can now view tailpipe CO₂ emission data for car rental listings and compare the emissions of electric, hybrid, and traditional vehicles. A similar informative function for airport transfers further empowers travellers to be informed with greener mobility choices across every leg of their journey. The Group's wider environmental efforts continue to scale. In 2024 alone, the Group has encouraged travellers to place over 100 million orders on more sustainable travel products. Solar panel installations at the Group's headquarters and rural retreats generated 457 MWh of clean electricity, offsetting more than 245 tons of CO₂ emissions. Additionally, Group increased its use of green electricity in leased data centres to 42.6%, underscoring its commitment to long-term decarbonisation and its 2050 carbon neutrality goal. Additionally, for the first time, the Group's report includes all categories from Scope 3 carbon emissions - covering sources such as leased data centres and business travel, to support more comprehensive tracking and target-setting in line with group's carbon neutrality target by 2050. Country Retreat Programme expands to more global destinations Group continued to make meaningful contributions to rural development and public safety through tourism. Its flagship Country Retreat Programme expanded to 34 sites, generating more than 40,000 indirect job opportunities. Over 80% of employees at these retreats are local residents, and participating villages reported an average rise in per capita income of USD 5,500. This year, the programme will expand to more global destinations. Additional childcare leave days, subsidies, and gender equity anchor Group's family-first culture Group has also strengthened its position as a leading family-friendly workplace. Women now account for 57.1% of its global workforce, with representation at senior and middle management levels reaching 32.7% and 43% respectively, and over 61.2% at entry-levels. The Group's hybrid work programme, launched in 2022, has been used over 630,000 times by employees, saving an estimated 1.25 million commuting hours and enhancing work-life flexibility. As part of its efforts to support families, the Group also provided an additional three days of childcare leave starting April this year to help working parents better balance personal and professional responsibilities. In addition, the group has enhanced its benefits for female employees seeking assisted reproductive medical services. Apart from egg freezing, eligible staff can receive a higher amount of subsidy of up to $20,900 USD for in vitro fertilisation. Meanwhile, the childcare subsidy programme, introduced in 2023, has provided cash bonuses for more than 900 children, with over USD 468,000 distributed in 2024 alone. Strong rating reinforces Group's governance focus Group continued to raise the bar in corporate governance, earning an A rating from MSCI ESG. Globally, the Group hosted two partner summits and deepened collaboration with more than 230 destination marketing organisations to drive inclusive tourism development. Ms Jane Sun, CEO of Group, said, "The ability to operate and grow more sustainably will be among the most critical factors for future competitiveness. We believe that sustainable development is a long-term journey requiring deep and enduring commitment. Together with our users, partners, and employees, we are working to build a future where every journey brings us closer - to one another, and to the perfect trip for a better world." For more information on Group's Sustainability report, please visit here. About Group Group is a leading global travel service provider comprising of Ctrip, Skyscanner, and Qunar. Across its platforms, Group helps travellers around the world make informed and cost-effective bookings for travel products and services and enables partners to connect their offerings with users through the aggregation of comprehensive travel-related content and resources, and an advanced transaction platform consisting of apps, websites and 24/7 customer service centres. Founded in 1999 and listed on NASDAQ in 2003 and HKEX in 2021, Group has become one of the best-known travel groups in the world, with the mission "to pursue the perfect trip for a better world". Find out more about Group here. Follow us on Twitter, Facebook, LinkedIn, and YouTube. SOURCE Group Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
